Abstract |
A 45-year-old man with paranoid schizophrenia repeatedly developed hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion ( SIADH), both after treatment with haloperidol and after taking quetiapine. This side effect did not occur subsequently during clozapine treatment. SIADH has been described in connection with almost all psychotropic drugs. Since the risk of developing SIADH is increased with increasing age, comorbid somatic disorders and polypharmacy, and the mean age of the psychiatric patient will further increase in the years to come, the physician should be alert to the risk factors and the clinical symptoms of disturbances in water balance; moreover, the proper differential diagnostic deliberations should be made. In case of increased risk, it is recommended to monitor the serum sodium during the first 2-4 weeks of pharmacotherapy.
|
Authors | O A van den Heuvel, P M Bet, E W C M van Dam, A M Eeckhout |
Journal | Nederlands tijdschrift voor geneeskunde
(Ned Tijdschr Geneeskd)
Vol. 150
Issue 35
Pg. 1944-8
(Sep 02 2006)
ISSN: 0028-2162 [Print] Netherlands |
Vernacular Title | Het syndroom van inadequate secretie van antidiuretisch hormoon (SIADH) tijdens het gebruik van de antipsychotica haloperidol en quetiapine. |
PMID | 16999280
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Antipsychotic Agents
- Dibenzothiazepines
- Quetiapine Fumarate
- Haloperidol
|
Topics |
- Age Factors
- Antipsychotic Agents
(adverse effects, therapeutic use)
- Dibenzothiazepines
(adverse effects, therapeutic use)
- Haloperidol
(adverse effects, therapeutic use)
- Humans
- Hyponatremia
(chemically induced)
- Inappropriate ADH Syndrome
(chemically induced)
- Male
- Middle Aged
- Quetiapine Fumarate
- Risk Factors
- Schizophrenia, Paranoid
(drug therapy)
|